Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.380
-0.030 (-2.13%)
At close: Jun 27, 2025, 4:00 PM
1.390
+0.010 (0.72%)
After-hours: Jun 27, 2025, 4:04 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $59.19 million as of June 27, 2025. Its market cap has decreased by -65.14% in one year.
Market Cap
59.19M
Enterprise Value
-63.67M
1-Year Change
-65.14%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $59.19M, a decrease of -93.74%. That is a compound annual growth rate of -42.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 60.48M | 8.60% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |